— Know what they know.
Not Investment Advice
Also trades as: GXI.DE (XETRA) · $vol 5M · GXI.SW (SIX) · $vol 0M

GRRMF OTC

Gerresheimer AG
1W: +0.0% 1M: -9.8% 3M: -4.8% YTD: -43.5% 1Y: -43.5% 3Y: -60.8% 5Y: -61.1%
$29.05
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Sell · Power 38 · $1.0B mcap · 32M float · 0.0005% daily turnover · Short 100% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.0B
52W Range19.165-51.41
Volume200
Avg Volume170
Beta0.47
Dividend—
Analyst Ratings
2 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOUwe Ferdinand Röhrhoff
Employees13,528
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2009-09-11
Peter-Müller-Straße 3
Düsseldorf, NW 40468
DE
49 211 61 81 00
About Gerresheimer AG

Gerresheimer AG, alongside its global subsidiaries, stands as a prominent manufacturer of packaging solutions and drug delivery devices. The company's operations are segmented into three primary divisions. The Plastics & Devices division supplies a comprehensive range of drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic tools, serving the pharmaceutical, biotechnology, diagnostics, and medical technology sectors. This segment also produces various plastic containers and closures, such as PET bottles, eye droppers, nasal sprays, nebulizers, and applicators, suitable for solid, liquid, and ophthalmic preparations, in addition to bottles for nutritional supplements. Its Primary Packaging Glass division specializes in essential glass packaging for both pharmaceutical and cosmetic industries. Offerings include infusion, dropper, and syrup bottles, injection vials, ampoules, and cartridges. This division also provides miniature bottles and glass containers for liquid food, spices, and spirits, as well as sophisticated packaging for fragrances, deodorants, skincare, wellness items, and diverse beauty and pharmaceutical products. The Advanced Technologies division is dedicated to pioneering smart drug delivery systems. A notable innovation is its micro-pumps, which empower patients to self-administer medications for conditions like Parkinson's disease or heart failure, catering to pharmaceutical and biotech clients. Established in 1864, the company's corporate headquarters are located in Düsseldorf, Germany.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms